CYSTAGON mercaptamine (cysteamine) (as bitartrate) 150mg capsule bottle Australia - English - Department of Health (Therapeutic Goods Administration)

cystagon mercaptamine (cysteamine) (as bitartrate) 150mg capsule bottle

alphapharm pty ltd - mercaptamine (cysteamine) bitartrate, quantity: 441.72 mg (equivalent: mercaptamine (cysteamine), qty 150 mg) - capsule, hard - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; magnesium stearate; sodium lauryl sulfate; silicon dioxide; croscarmellose sodium; titanium dioxide; gelatin; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - for the management of nephropathic cystinosis in children and adults.

CYSTAGON mercaptamine (cysteamine) (as bitartrate) 50mg capsule  bottle Australia - English - Department of Health (Therapeutic Goods Administration)

cystagon mercaptamine (cysteamine) (as bitartrate) 50mg capsule bottle

alphapharm pty ltd - mercaptamine (cysteamine) bitartrate, quantity: 147.24 mg (equivalent: mercaptamine (cysteamine), qty 50 mg) - capsule, hard - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; magnesium stearate; sodium lauryl sulfate; silicon dioxide; croscarmellose sodium; titanium dioxide; gelatin; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - for the management of nephropathic cystinosis in children and adults.

Cystagon European Union - English - EMA (European Medicines Agency)

cystagon

recordati rare diseases - mercaptamine bitartrate - cystinosis - other alimentary tract and metabolism products, - cystagon is indicated for the treatment of proven nephropathic cystinosis. cysteamine reduces cystine accumulation in some cells (e.g. leukocytes, muscle and liver cells) of nephropathic cystinosis patients and, when treatment is started early, it delays the development of renal failure.

CYSTADROPS  3.8 MGML Israel - English - Ministry of Health

cystadrops 3.8 mgml

medison pharma ltd - mercaptamine as hydrochloride - ophthalmic solution - mercaptamine as hydrochloride 3.8 mg - mercaptamine - cystadrops is indicated for the treatment of corneal cystine crystal deposits in adults and children from 2 years of age with cystinosis.